JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB188826

Alpha-synuclein (phospho S129) peptide

Be the first to review this product! Submit a review

|

(6 Publications)

Alpha-synuclein (phospho S129) peptide is a Synthetic blocking peptide.

View Alternative Names

NACP, PARK1, SNCA, Alpha-synuclein, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor

Key facts

Tags

Tag free

Applications

BL

applications

Biologically active

No

Accession

P37840

Animal free

No

Carrier free

No

Species

Human

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "BL": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

- First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
- If the peptide doesn't dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
- Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
- Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
- Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

Sequence info

[{"sequence":null,"proteinLength":null,"predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Synthetic","expressionSystem":null,"accessionNumber":"P37840","tags":[]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
-20°C
False

Specifications

Form

Lyophilized

General info

Function

The protein expressed by the SNCA gene is involved in various synaptic activities, including the regulation of synaptic vesicle trafficking and neurotransmitter release. As a monomer, it enhances synaptic vesicle exocytosis through vesicle priming, fusion, and dilation of exocytotic fusion pores. Mechanistically, it increases local Ca(2+) release, which is crucial for ATP-induced exocytosis. In its multimeric membrane-bound form, SNCA acts as a molecular chaperone, assisting in the folding of synaptic fusion components known as SNAREs at the presynaptic plasma membrane, in conjunction with cysteine string protein-alpha/DNAJC5, a function that is vital for maintaining normal SNARE-complex assembly during aging. Additionally, SNCA plays a role in dopamine neurotransmission regulation by associating with the dopamine transporter (DAT1) and modulating its activity. This supplementary information is collated from multiple sources and compiled automatically.

Sequence similarities

Belongs to the synuclein family.

Post-translational modifications

Phosphorylated, predominantly on serine residues. Phosphorylation by CK1 appears to occur on residues distinct from the residue phosphorylated by other kinases. Phosphorylation of Ser-129 is selective and extensive in synucleinopathy lesions. In vitro, phosphorylation at Ser-129 promoted insoluble fibril formation. Phosphorylated on Tyr-125 by a PTK2B-dependent pathway upon osmotic stress.. Hallmark lesions of neurodegenerative synucleinopathies contain alpha-synuclein that is modified by nitration of tyrosine residues and possibly by dityrosine cross-linking to generated stable oligomers.. Ubiquitinated. The predominant conjugate is the diubiquitinated form.. Acetylation at Met-1 seems to be important for proper folding and native oligomeric structure.

Product protocols

Target data

The protein expressed by the SNCA gene is involved in various synaptic activities, including the regulation of synaptic vesicle trafficking and neurotransmitter release. As a monomer, it enhances synaptic vesicle exocytosis through vesicle priming, fusion, and dilation of exocytotic fusion pores. Mechanistically, it increases local Ca(2+) release, which is crucial for ATP-induced exocytosis. In its multimeric membrane-bound form, SNCA acts as a molecular chaperone, assisting in the folding of synaptic fusion components known as SNAREs at the presynaptic plasma membrane, in conjunction with cysteine string protein-alpha/DNAJC5, a function that is vital for maintaining normal SNARE-complex assembly during aging. Additionally, SNCA plays a role in dopamine neurotransmission regulation by associating with the dopamine transporter (DAT1) and modulating its activity. This supplementary information is collated from multiple sources and compiled automatically.
See full target information SNCA phospho S129

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Brain : a journal of neurology 147:444-457 PubMed38006313

2023

Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Yaping Chu,Warren D Hirst,Howard J Federoff,Ashley S Harms,A Jon Stoessl,Jeffrey H Kordower

ACS measurement science au 2:485-492 PubMed36785659

2022

Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction.

Applications

Unspecified application

Species

Unspecified reactive species

Hsin-Hsien Chen,Ming-Hung Hsu,Kun-Hung Lee,Shieh-Yueh Yang

Acta neuropathologica communications 10:98 PubMed35794636

2022

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.

Applications

Unspecified application

Species

Unspecified reactive species

David J Koss,Daniel Erskine,Andrew Porter,Pawel Palmoski,Hariharan Menon,Olivia G J Todd,Marta Leite,Johannes Attems,Tiago F Outeiro

Acta neuropathologica 142:807-825 PubMed34453582

2021

Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Zhao,Wenyan Lu,Yingxue Ren,Yuan Fu,Yuka A Martens,Francis Shue,Mary D Davis,Xue Wang,Kai Chen,Fuyao Li,Chia-Chen Liu,Neill R Graff-Radford,Zbigniew K Wszolek,Steven G Younkin,David A Brafman,Nilüfer Ertekin-Taner,Yan W Asmann,Dennis W Dickson,Ziying Xu,Meixia Pan,Xianlin Han,Takahisa Kanekiyo,Guojun Bu

BMC complementary medicine and therapies 20:73 PubMed32143619

2020

Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.

Applications

Unspecified application

Species

Unspecified reactive species

Mustafa T Ardah,Simona S Ghanem,Sara A Abdulla,Guohua Lv,Mohamed M Emara,Katerina E Paleologou,Nishant N Vaikath,Jia-Hong Lu,Min Li,Konstantinos Vekrellis,David Eliezer,Omar M A El-Agnaf

Acta neuropathologica 135:877-886 PubMed29536165

2018

Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.

Applications

IHC-P

Species

Human

Ivan Martinez-Valbuena,Irene Amat-Villegas,Rafael Valenti-Azcarate,Maria Del Mar Carmona-Abellan,Irene Marcilla,Maria-Teresa Tuñon,Maria-Rosario Luquin
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com